Australia Court Nullifies Patents For AZ's Crestor, Freeing Generics To Sell
This article was originally published in PharmAsia News
Executive Summary
An Australia federal court denied patent protection for AstraZeneca's Crestor, freeing Canada's Apotex to market a generic of the cholesterol drug.